Tiazesim
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
5-[2-(dimethylamino)ethyl]-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
| Clinical data | |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 5845-26-1 3122-01-8 (hydrochloride) |
| ATC code | None |
| PubChem | CID 22107 |
| ChemSpider | 20775 |
| UNII | 44G76ZB85O |
| KEGG | D02699 |
| ChEMBL | CHEMBL2111123 |
| Synonyms | SQ-10,496 |
| Chemical data | |
| Formula | C19H22N2OS |
| Molar mass | 326.456 g/mol |
|
|
|
Tiazesim (INN; brand name Altinil), also known as thiazesim (BAN, USAN) or thiazenone, is a heterocyclic antidepressant related to the tricyclics which, first introduced in 1966 by Squibb Corporation (now Bristol-Myers Squibb), has since been discontinued and is no longer marketed.[1][2]
See also[edit]
References[edit]
- ^ C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 1973. ISBN 978-0-412-46630-4. Retrieved 29 November 2011.
- ^ The United States patents quarterly. 1969. Retrieved 1 May 2012.
|

